Heart Total Assets from 2010 to 2025

HSCS Stock

USD 2.91 0.01 0.34%

Heart Test Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets are likely to outpace its year average in 2025. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

10.9 M

Current Value

11.5 M

Quarterly Volatility

3.5 M

Credit Downgrade

Yuan Drop

Covid

Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 150, Dividend Yield of 0.0 or PTB Ratio of 0.49. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.

Check out the analysis of Heart Test Correlation against competitors.

Latest Heart Test's Total Assets Growth Pattern

Below is the plot of the Total Assets of Heart Test Laboratories over the last few years. Total assets refers to the total amount of Heart Test assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Heart Test Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Heart Test's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 9.5 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Heart Total Assets Regression Statistics

	Arithmetic Mean	3,673,082
	Geometric Mean	2,782,667
	Coefficient Of Variation	95.01
	Mean Deviation	2,610,932
	Median	1,955,856
	Standard Deviation	3,489,933
	Sample Variance	12.2T
	Range	9.5M
	R-Value	0.71
	Mean Square Error	6.4T
	R-Squared	0.51
	Significance	0
	Slope	522,394
	Total Sum of Squares	182.7T

Heart Total Assets History

	2025	11.5 M
	2024	10.9 M
	2023	9.5 M
	2022	3.3 M
	2021	2.1 M
	2020	1.9 M

Other Fundumenentals of Heart Test Laboratories

Intangibles To Total Assets

Heart Test Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Good Will	Intangible Assets
Total Assets		0.9	0.14	0.77	-0.85	-0.86	0.42	-0.09	0.99	0.16	0.99	0.2	1.0	-0.53	0.98	0.21	-0.51	0.54	0.8	-0.8
Total Stockholder Equity	0.9		0.55	0.48	-0.99	-0.66	0.06	-0.5	0.94	-0.28	0.93	-0.22	0.89	-0.52	0.97	-0.21	-0.5	0.73	0.71	-0.72
Net Tangible Assets	0.14	0.55		-0.32	-0.62	0.09	-0.57	-0.99	0.24	-0.92	0.21	-0.88	0.11	-0.01	0.32	-0.89	-0.01	0.68	0.1	-0.1
Current Deferred Revenue	0.77	0.48	-0.32		-0.45	-0.91	0.8	0.36	0.73	0.54	0.7	0.56	0.78	-0.12	0.65	0.56	-0.1	0.4	0.63	-0.46
Net Debt	-0.85	-0.99	-0.62	-0.45		0.65	-0.02	0.58	-0.9	0.37	-0.88	0.3	-0.84	0.44	-0.93	0.29	0.42	-0.8	-0.62	0.6
Retained Earnings	-0.86	-0.66	0.09	-0.91	0.65		-0.69	-0.14	-0.85	-0.39	-0.82	-0.39	-0.87	0.16	-0.79	-0.39	0.15	-0.47	-0.52	0.56
Accounts Payable	0.42	0.06	-0.57	0.8	-0.02	-0.69		0.55	0.37	0.79	0.32	0.82	0.45	0.22	0.25	0.8	0.23	0.02	0.34	-0.36
Long Term Debt	-0.09	-0.5	-0.99	0.36	0.58	-0.14	0.55		-0.19	0.92	-0.16	0.84	-0.06	0.0	-0.26	0.84	0.0	-0.66	-0.06	0.06
Net Receivables	0.99	0.94	0.24	0.73	-0.9	-0.85	0.37	-0.19		0.07	0.99	0.1	0.99	-0.48	0.99	0.11	-0.47	0.61	0.78	-0.79
Total Liab	0.16	-0.28	-0.92	0.54	0.37	-0.39	0.79	0.92	0.07		0.08	0.95	0.19	0.01	-0.03	0.94	0.01	-0.53	0.13	-0.23
Net Invested Capital	0.99	0.93	0.21	0.7	-0.88	-0.82	0.32	-0.16	0.99	0.08		0.12	0.99	-0.58	0.99	0.13	-0.57	0.56	0.79	-0.8
Short Long Term Debt	0.2	-0.22	-0.88	0.56	0.3	-0.39	0.82	0.84	0.1	0.95	0.12		0.23	-0.08	0.0	1.0	-0.08	-0.45	0.17	-0.22
Total Current Assets	1.0	0.89	0.11	0.78	-0.84	-0.87	0.45	-0.06	0.99	0.19	0.99	0.23		-0.52	0.97	0.24	-0.5	0.53	0.79	-0.8
Capital Stock	-0.53	-0.52	-0.01	-0.12	0.44	0.16	0.22	0.0	-0.48	0.01	-0.58	-0.08	-0.52		-0.54	-0.13	1.0	0.02	-0.45	0.45
Net Working Capital	0.98	0.97	0.32	0.65	-0.93	-0.79	0.25	-0.26	0.99	-0.03	0.99	0.0	0.97	-0.54		0.01	-0.53	0.63	0.78	-0.78
Short Term Debt	0.21	-0.21	-0.89	0.56	0.29	-0.39	0.8	0.84	0.11	0.94	0.13	1.0	0.24	-0.13	0.01		-0.13	-0.46	0.18	-0.23
Common Stock	-0.51	-0.5	-0.01	-0.1	0.42	0.15	0.23	0.0	-0.47	0.01	-0.57	-0.08	-0.5	1.0	-0.53	-0.13		0.03	-0.44	0.44
Property Plant Equipment	0.54	0.73	0.68	0.4	-0.8	-0.47	0.02	-0.66	0.61	-0.53	0.56	-0.45	0.53	0.02	0.63	-0.46	0.03		0.47	-0.2
Good Will	0.8	0.71	0.1	0.63	-0.62	-0.52	0.34	-0.06	0.78	0.13	0.79	0.17	0.79	-0.45	0.78	0.18	-0.44	0.47		-0.8
Intangible Assets	-0.8	-0.72	-0.1	-0.46	0.6	0.56	-0.36	0.06	-0.79	-0.23	-0.8	-0.22	-0.8	0.45	-0.78	-0.23	0.44	-0.2	-0.8

Click cells to compare fundamentals

About Heart Test Financial Statements

Heart Test shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	10.9 M	11.5 M
Intangibles To Total Assets	0.15	0.14

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC